Management of NSCLC (NSCLC) has emerged as a fundamental within the quickly advancing field of oncology, because of the deliberate arrangement of specific treatments like afatinib and osimertinib.The complex procedure of identifying the optimal order of these medications for each patient is referred to as afatinib-osimertinib treatment sequencing.This article investigates the importance of this treatment order, examining the fundamental reasons, difficulties, and possible resolutions to enhance treatment results.Both afatinib and osimertinib are targeted kinase inhibitors (TKIs) that bind to the EGFR (EGFR) in NSCLC (NSCLC).Figuring out the optimal treatment sequence…
